S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cotinga Pharmaceuticals Inc. (COT.V)SalvaRx GroupPacgen Life Science Co. (PBS.V)Port Erin Biopharma InvestmentsMedifocus Inc. (MFS.V)
Price Information
Current PriceC$0.04GBX 4.50C$0.03GBX 4.50C$0.01
52 Week RangeN/AN/AN/AN/AN/A
Overall Score0.
Analysis Score0.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapC$1.54 million£1.65 millionC$1.30 million£1.04 millionC$925,000.00
Average Volume20,28150,75863,60143,123317,764
Sales & Book Value
Annual RevenueN/A£64.50 millionC$302,079.00£28,300.00C$2.23 million
Price / SalesN/A0.036.4436.880.83
CashflowC$0.00 per shareGBX 1.29 per shareC$0.00 per shareGBX 8.20 per shareC$0.00 per share
Price / Cash17.503.5030.000.5510.00
Book ValueC($0.18) per shareGBX 15.40 per shareC$0.00 per shareGBX 8.10 per shareC($0.07) per share
Price / BookN/A0.00-30.000.01-0.15
Net IncomeN/AN/AN/AN/AN/A
EPSC($0.12)GBX 168.80C($0.01)GBX (0.70)C($0.01)
Trailing P/E RatioN/A0.03N/AN/AN/A
Forward P/E Ratio
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutC$0.24N/AC$0.09N/AN/A
Dividend Yield685.71%N/A300.00%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A N/AN/A N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A14.50%78.48%N/AN/A
Current Ratio0.05%1.89%0.81%59.77%0.04%
Quick Ratio0.01%1.89%0.40%59.77%0.03%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding21.99 million36.70 million64.82 million23.20 million184.98 million
Next Earnings Date4/7/2021 (Estimated)N/AN/AN/A3/1/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.